ArticleJournal of comparative effectiveness research2020

Real-world direct healthcare costs of treating recurrent high-grade serous ovarian cancer with cytotoxic chemotherapy.

Lucy Gilbert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.